The impact of the COVID-19 pandemic on blood pressure control in patients with treated hypertension-results of the European Society of Hypertension Study (ESH ABPM COVID-19 Study).

Autor: Wojciechowska W; Jagiellonian University Medical College, 1st Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Krakow, Poland., Rajzer M; Jagiellonian University Medical College, 1st Department of Cardiology, Interventional Electrocardiology and Arterial Hypertension, Krakow, Poland., Kreutz R; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Institute of Clinical Pharmacology and Toxicology, Berlin, Germany., Weber T; Cardiology Department Klinikum Wels-Grieskirchen, Wels, Austria., Bursztyn M; Faculty of Medicine, Hadassah-Hebrew University Jerusalem, Hadassah-Hebrew University Medical Center Mount-Scopus, Jerusalem, Israel., Persu A; Division of Cardiology, Department of Cardiovascular Diseases, Cliniques Universitaires Saint-Luc and Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium., Stergiou G; Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece., Parati G; Department of Medicine and Surgery, University of Milano-Bicocca.; Department of Cardiology, S. Luca Hospital, IRCCS, Istituto Auxologico Italiano, Milan, Italy., Bilo G; Department of Medicine and Surgery, University of Milano-Bicocca.; Department of Cardiology, S. Luca Hospital, IRCCS, Istituto Auxologico Italiano, Milan, Italy., Pac A; Department of Epidemiology, Chair of Epidemiology and Preventive Medicine, Jagiellonian University Medical College, Krakow, Poland., Grassi G; Clinica Medica, Dept of Medicine and Surgery, University of Milano Bicocca, Milan Italy., Mancia G; Department of Medicine and Surgery, University of Milano-Bicocca., Januszewicz A; Department of Hypertension, National Institute of Cardiology, Warsaw, Poland., Chrostowska M; Hypertension Unit, Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland., Narkiewicz K; Hypertension Unit, Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland., Dubiela A; Hypertension Unit, Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland., Doumas M; 2nd Prop Department of Internal Medicine, Aristotle University, Thessaloniki, Greece., Imprialos K; 2nd Prop Department of Internal Medicine, Aristotle University, Thessaloniki, Greece., Stavropoulos K; 2nd Prop Department of Internal Medicine, Aristotle University, Thessaloniki, Greece., de Freminville JB; Université Paris Cité, F75006, Paris, France; APHP, Hôpital Européen Georges Pompidou, Hypertension department, F-75015, Paris, France., Azizi M; Université Paris Cité, F75006, Paris, France; APHP, Hôpital Européen Georges Pompidou, Hypertension department, F-75015, Paris, France., Cunha PG; Centre for the Research and Treatment of Arterial Hypertension, Guimarães, Portugal, Minho Medical School, Minho University, Portugal., Lewandowski J; Department of Internal Medicine, Hypertension and Vascular Diseases, Medical University of Warsaw, Warsaw, Poland., Strzelczyk J; Department of Internal Medicine, Hypertension and Vascular Diseases, Medical University of Warsaw, Warsaw, Poland., Wuerzner G; Hypertension Centre of the Lausanne University Hospital, Service of Nephrology and Hypertension, Lausanne, Switzerland., Gosk-Przybyłek M; National Institute of Cardiology, Warsaw, Poland., Szwench-Pietrasz E; National Institute of Cardiology, Warsaw, Poland., Prejbisz A; National Institute of Cardiology, Warsaw, Poland., Van der Niepen P; Department of Nephrology and Hypertension, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium., Kahan T; Cardiovascular Risk Assessment Unit, Department of Cardiology, Danderyd University Hospital, Stockholm, Sweden., Jekell A; Cardiovascular Risk Assessment Unit, Department of Cardiology, Danderyd University Hospital, Stockholm, Sweden., Spaak J; Cardiovascular Risk Assessment Unit, Department of Cardiology, Danderyd University Hospital, Stockholm, Sweden., Tsioufis K; First Cardiology Clinic, Medical School, National and Kapodistrian University of Athens, Hippokration Hospital, Athens, Greece., Ehret G; Department of Cardiology, Geneva University Hospitals, Geneva, Switzerland., Doroszko A; Clinical Department of Internal Diseases, Hypertension and Clinical Oncology, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland., Kubalski P; Hypertension and Diabetes Centre, Grudziadz., Polonia J; Faculty of Medicine, University of Porto, & Hypertension, HTA and Cardiovascular Risk Unit, ULS Matosinhos, Matosinhos, Portugal., Styczkiewicz K; Department of Internal Medicine, Institute of Medical Sciences, Medical College, University of Rzeszów, Poland., Styczkiewicz M; Department of Cardiology, The Pope John Paul II Province Hospital of Zamość, Zamość, Poland., Mazur S; MEDYK Medical Center in Rzeszów., Veglio F; Hypertension Unit, Division of Internal Medicine, Department of Medical Sciences, AO 'Città della Salute e della Scienza' University Hospital, Turin, Italy., Rabbia F; Hypertension Unit, Division of Internal Medicine, Department of Medical Sciences, AO 'Città della Salute e della Scienza' University Hospital, Turin, Italy., Eula E; Hypertension Unit, Division of Internal Medicine, Department of Medical Sciences, AO 'Città della Salute e della Scienza' University Hospital, Turin, Italy., Águila FJ; Vascular Risk Unit. Internal Medicine. Virgen de las Nieves University Hospital. Granada. Spain., Sarzani R; Internal Medicine and Geriatrics, University Politecnica delle Marche, and IRCCS INRCA, Ancona, Italy., Spannella F; Internal Medicine and Geriatrics, University Politecnica delle Marche, and IRCCS INRCA, Ancona, Italy., Jarai Z; Department of Cardiology, South-Buda Center Hospital - St Imre University Teaching Hospital, Budapest, Hungary., Papadopoulos D; Hypertension Clinic, University Hospital Laiko, Athens, Greece., Lopez-Sublet M; AP-HP, Hôpital Avicenne, Centre d'Excellence Européen en Hypertension Artérielle, Service de Médecine Interne, Bobigny, France. INSERM UMR 942 MASCOT, Paris 13-Université Paris Nord. FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France., Ostrowska A; First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University, Medical College, Krakow, Poland., Grassos C; Hypertension Clinic, Department of Cardiology, KAT General Hospital, Athens, Greece., Kahrimanidis I; Hypertension Clinic, Department of Cardiology, KAT General Hospital, Athens, Greece., Eugenia G; Third Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Areti T; Third Department of Internal Medicine, Papageorgiou Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece., Tomasz G; Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland., Barbara W; Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland., Aleksandra S; Department of Internal Medicine and Gerontology, Jagiellonian University Medical College, Krakow, Poland., Beata M; Department of Cardiology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland., Angeliki N; Hypertension Center STRIDE-7, School of Medicine, Third Department of Medicine, Sotiria Hospital, National and Kapodistrian University of Athens, Greece., Robles NR; Hospital Universitario de Badajoz, Badajoz, Spain., Widmiski J; Center for Hypertension, Charles University, Prague, Czech Republic., Zbroch E; Department of Internal Medicine and Hypertension, Medical University of Bialystok, Bialystok, Poland.
Jazyk: angličtina
Zdroj: Journal of hypertension [J Hypertens] 2024 Dec 01; Vol. 42 (12), pp. 2065-2074. Date of Electronic Publication: 2024 Sep 19.
DOI: 10.1097/HJH.0000000000003752
Abstrakt: Background: We aimed to determine the influence of coronavirus disease 2019 (COVID-19) pandemic on blood pressure (BP) control assessed by ambulatory blood pressure monitoring (ABPM).
Methods: Office BP and ABPM data from two visits conducted within a 9-15 months interval were collected from patients treated for hypertension. In the prepandemic group, both visits took place before, while in the pandemic group, Visit-1 was done before and Visit-2 during the pandemic period.
Results: Of 1811 collected patients 191 were excluded because they did not meet the required ABPM time frames. Thus, the study comprised 704 patients from the pandemic and 916 from the prepandemic group. Groups did not differ in sex, age, duration of hypertension, frequency of first line antihypertensive drug use and mean 24 h BP on Visit-1. The prevalence of sustained uncontrolled hypertension was similar in both groups. On Visit-2 mean 24 h BP, daytime and nighttime systolic BP and diastolic BP were higher in the pandemic compared to the prepandemic group ( P  < 0.034). The prevalence of sustained uncontrolled hypertension on Visit-2 was higher in the pandemic than in the prepandemic group [0.29 (95% confidence interval (95% CI): 0.26-0.33) vs. 0.25 (95% CI: 0.22-0.28), P  < 0.037]. In multivariable adjusted analyses a significant difference in BP visit-to-visit change was observed, with a more profound decline in BP between visits in the prepandemic group.
Conclusions: This study using ABPM indicates a negative impact of the COVID-19 pandemic on BP control. It emphasizes the need of developing strategies to maintain BP control during a pandemic such as the one induced by COVID-19.
(Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: